NDC 67919-030 – Zerbaxa
Ceftolozane Sulfate 1 g/10mL; Tazobactam Sodium .5 g/10mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC67919-030
Product details
- Brand name
- Zerbaxa
- Generic name
- Ceftolozane and tazobactam
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA206829
- Marketed since
- December 19, 2014
- Listing expires
- December 31, 2027
- Pharmacologic class
- Cephalosporin Antibacterial; beta Lactamase Inhibitor
Active ingredients
- Ceftolozane Sulfate 1 g/10mL
- Tazobactam Sodium .5 g/10mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 67919-030-01 | 10 VIAL, SINGLE-DOSE in 1 CARTON (67919-030-01) / 10 mL in 1 VIAL, SINGLE-DOSE | Dec 19, 2014 |
Recalls mentioning this NDC
- D-0176-2021 Jan 13, 2021 · Class II
Lack of assurance of sterility: The results of sterility tests of seven batches of product were out of specification. Five of these batches tested positive for Ralstonia pickettii and two batches…